Cancer Letters
Volume 291, Issue 1 , Pages 108-119 , 1 May 2010

Marchantin A, a cyclic bis(bibenzyl ether), isolated from the liverwort Marchantia emarginata subsp. tosana induces apoptosis in human MCF-7 breast cancer cells

  • Wei-Jan Huang

      Affiliations

    • Graduate Institute of Pharmacognosy, Taipei Medical University, Taipei 110, Taiwan
    • ,
  • Chia-Li Wu

      Affiliations

    • Department of Chemistry, Tamkang University, Tamsui 251, Taiwan
    • ,
  • Chia-Wei Lin

      Affiliations

    • Naturewise Biotech and Medicals Corporation, Taipei 115, Taiwan
    • ,
  • Li-Ling Chi

      Affiliations

    • Naturewise Biotech and Medicals Corporation, Taipei 115, Taiwan
    • ,
  • Pen-Yuan Chen

      Affiliations

    • Naturewise Biotech and Medicals Corporation, Taipei 115, Taiwan
    • ,
  • Chun-Jung Chiu

      Affiliations

    • Naturewise Biotech and Medicals Corporation, Taipei 115, Taiwan
    • ,
  • Chung-Yang Huang

      Affiliations

    • Naturewise Biotech and Medicals Corporation, Taipei 115, Taiwan
    • ,
  • Chia-Nan Chen

      Affiliations

    • Naturewise Biotech and Medicals Corporation, Taipei 115, Taiwan
    • Corresponding Author InformationCorresponding author. Address: Center of Research and Development, NatureWise Biotech and Medicals Corporation, ER-13, 17 Fl., No. 3, Yuan-Qu St., Nankang, Taipei 115, Taiwan. Tel.: +886 2 2655 9109; fax: +886 2 2655 9110.

Received 30 June 2009 ,Revised 3 October 2009 ,Accepted 9 October 2009.

References 

  1. Asakawa Y. Chemical constituents of the bryophytes. Progress in the Chemistry of Organic Natural Products. 1995;65:1–618
  2. Toyota M, Omatsu I, Braggins J, Asakawa Y. New humulane-type sesquiterpenes from the liverworts Tylimanthus tenellus and Marchantia emarginata subsp. tosana. Chem. Pharm. Bull. (Tokyo). 2004;52:481–484
  3. Niu C, Qu JB, Lou HX. Antifungal bis(bibenzyls) from the Chinese liverwort Marchantia polymorpha L. Chem. Biodivers. 2006;3:34–40
  4. Kámory E, Keserü GM, Papp B. Isolation and antibacterial activity of marchantin A, a cyclic bis(bibenzyl) constituent of Hungarian Marchantia polymorpha. Planta Med. 1995;61:387–388
  5. Harinantenaina L, Quang DN, Takeshi N, Hashimoto T, Kohchi C, Soma G, et al. Bis(bibenzyls) from liverworts inhibit lipopolysaccharide-induced inducible NOS in RAW 264.7 cells: a study of structure–activity relationships and molecular mechanism. J. Nat. Prod. 2005;68:1779–1781
  6. Taira Z, Takei M, Endo K, Hashimoto T, Sakiya Y, Asakawa Y. Marchantin A trimethyl ether: its molecular structure and tubocurarine-like skeletal muscle relaxation activity. Chem. Pharm. Bull. (Tokyo). 1994;42:52–56
  7. Askawa Y. Phytochemistry of bryophytes: biologically active terpenoids and aromatic compounds from liverworts. In:  Romeo J editors. Phytochemicals in Human Health Protection, Nutrition, and Plant Defense. vol. 33:New York: Kluwer Academic/Plenum Publishers; 1999;p. 319–342
  8. Wyllie AH. Apoptosis: an overview. Br. Med. Bull. 1997;53:451–465
  9. Don AS, Hogg PJ. Mitochondria as cancer drug targets. Trends Mol. Med. 2004;10:372–378
  10. Grad JM, Cepero E, Boise LH. Mitochondria as targets for established and novel anti-cancer agents. Drug Resist. Updates. 2001;4:85–91
  11. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309–1312
  12. Fleury C, Mignotte B, Vayssiere JL. Mitochondrial reactive oxygen species in cell death signaling. Biochimie. 2002;84:131–141
  13. Reeder JG, Vogel VG. Breast cancer risk management. Clin. Breast Cancer. 2007;7:833–840
  14. Newman DJ, Cragg GM, Snader KM. The influence of natural products upon drug discovery. Nat. Prod. Rep. 2000;17:215–234
  15. Tori M, Toyota M, Harrison LJ, Takikawa K, Asakawa Y. Total assignment of 1H and 13C NMR spectra of marchantins isolated from liverworts and its application to structure determination of two new macrocyclic bis(bibenzyls). Tetrahedron Lett. 1985;26:4735–4738
  16. Shi YQ, Zhu CJ, Yuan HQ, Li BQ, Gao J, Qu XJ, et al. Marchantin C, a novel microtubule inhibitor from liverwort with anti-tumor activity both in vivo and in vitro. Cancer Lett. 2009;276:160–170
  17. Kuribayashi K, Mayes PA, El-Deiry WS. What are caspases 3 and 7 doing upstream of the mitochondria?. Cancer Biol. Ther. 2006;5:763–765
  18. Kruidering M, Evan GI. Caspase-8 in apoptosis: the beginning of “the end”?. IUBMB Life. 2000;50:85–90
  19. Caldon CE, Daly RJ, Sutherland RL, Musgrove EA. Cell cycle control in breast cancer cells. J. Cell Biochem. 2006;1:61–74
  20. Dotto GP. p21(WAF1/Cip1): more than a break to the cell cycle?. Biochim. Biophys. Acta. 2000;1471:43–56
  21. Pines J, Hunter T. Cyclins A and B1 in the human cell cycle. CIBA Found. Symp. 1992;170:187–196
  22. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene. 2006;13:1620–1628
  23. Lopez-Beltran A, MacLennan GT, Montironi R. Cyclin E as molecular marker in the management of breast cancer: a review. Anal. Quant. Cytol. Histol. 2006;28:111–114
  24. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995;9:1149–1163
  25. Liu G, Lozano G. p21 Stability: linking chaperones to a cell cycle checkpoint. Cancer Cell. 2005;7:113–114
  26. Kumagai T, Wakimoto N, Yin D, Gery S, Kawamata N, Takai N, et al. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells. Int. J. Cancer. 2007;121:656–665
  27. Noh EJ, Lim DS, Jeong G, Lee JS. An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner. Biochem. Biophys. Res. Commun. 2009;378:326–331
  28. Pajak B, Orzechowski A, Gajkowska B. Molecular basis of sodium butyrate-dependent proapoptotic activity in cancer cells. Adv. Med. Sci. 2007;52:83–88
  29. Rosato RR, Almenara JA, Maggio SC, Coe S, Atadja P, Dent P, et al. Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions. Mol. Cancer Ther. 2008;7:3285–3297
  30. Rosato RR, Almenara JA, Grant S. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. Cancer Res. 2003;63:3637–3645
  31. Grunberger D, Banerjee R, Eisinger K, Oltz EM, Efros L, Caldwell M, et al. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia. 1988;15:230–232
  32. Cao G, Sofic E, Prior RL. Antioxidant and prooxidant behavior of flavonoids: structure–activity relationships. Free Rad. Biol. Med. 1997;22:749–760
  33. Wee LM, Long LH, Whiteman M, Halliwell B. Factors affecting the ascorbate- and phenolic-dependent generation of hydrogen peroxide in Dulbecco’s modified Eagle’s medium. Free Rad. Res. 2003;37:1123–1130
  34. Roques SC, Landrault N, Teissèdre PL, Laurent C, Besançon P, Rouane JM, et al. Hydrogen peroxide generation in caco-2 cell culture medium by addition of phenolic compounds: effect of ascorbic acid. Free Rad. Res. 2002;36:593–599

PII: S0304-3835(09)00628-4

doi: 10.1016/j.canlet.2009.10.006

Cancer Letters
Volume 291, Issue 1 , Pages 108-119 , 1 May 2010

Article Tools

* Image Usage & Resolution